News

A new pre-print study shared by Professor Alex Sigal’s laboratory at the Africa Health Research Institute is the first scientific data to be published on Omicron. Let's break down the findings.

Researchers have developed the world’s first metal-organic framework (MOFs) antibody-drug delivery system that has the potential to fast-track potent new therapies for cancer, cardiovascular and autoimmune diseases.

Scientists believe they may have found a way to reverse an aggressive, treatment-resistant type of breast cancer into a less dangerous kind that responds well to treatment.

A new study published in eLife demonstrates the therapeutic potential of nanobodies – miniature antibodies derived from llamas – against SARS-CoV-2.

Researchers have paired a catalyst called “Barton’s base” developed in the 1980s with a new family of chemical reactions. This combination can accelerate the generation of complex molecules needed for biomedical research, drug development and materials science.

Chemists have created a new methodology that rapidly generates millions of combinations of small molecules through programmed assembly using DNA-pairing processes.

Researchers have created more accurate preclinical models of advanced human gastric cancer development.

A research team has produced two molecules that are usually only formed by microorganisms found in contaminated wastewater in an abandoned mine in South Korea. The approach could pave the way for new types of drugs.

Researchers have designed a new nanoparticle adjuvant that may be more potent than others now in use. Studies in mice showed that it significantly improved antibody production following vaccination against HIV, diphtheria and influenza.

A study looking at the potential of repurposing licensed drugs for the treatment of Alzheimer’s disease has identified the erectile dysfunction drug sildenafil, trade name Viagra, as a candidate for future analysis.